Eugia Pharma Company Profile

What is the competitive landscape for EUGIA PHARMA, and what generic alternatives to EUGIA PHARMA drugs are available?

EUGIA PHARMA has one hundred and forty-two approved drugs.

There is one US patent protecting EUGIA PHARMA drugs. There are seven tentative approvals on EUGIA PHARMA drugs.

There are ten patent family members on EUGIA PHARMA drugs in nine countries and two hundred and sixty-one supplementary protection certificates in fifteen countries.

Summary for Eugia Pharma

International Patents:	10
US Patents:	1
Tradenames:	118
Ingredients:	110
NDAs:	142
Patent Litigation for Eugia Pharma:	See patent lawsuits for Eugia Pharma

Drugs and US Patents for Eugia Pharma

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eugia Pharma	ERLOTINIB HYDROCHLORIDE	erlotinib hydrochloride	TABLET;ORAL	216342-002	Jun 22, 2022	AB	RX	No	No
Eugia Pharma	DEXMEDETOMIDINE HYDROCHLORIDE	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	205867-001	Mar 17, 2016	AP	RX	No	No
Eugia Pharma	KETOROLAC TROMETHAMINE	ketorolac tromethamine	SOLUTION/DROPS;OPHTHALMIC	205190-001	Dec 3, 2020		DISCN	No	No
Eugia Pharma	KETOROLAC TROMETHAMINE	ketorolac tromethamine	INJECTABLE;INJECTION	212939-002	Oct 20, 2020		DISCN	No	No
Eugia Pharma	VECURONIUM BROMIDE	vecuronium bromide	INJECTABLE;INJECTION	206670-001	Dec 20, 2018	AP	RX	No	No
Eugia Pharma	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	207160-003	Jan 4, 2017	AP	RX	No	No
Eugia Pharma	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	205487-001	Mar 28, 2016	AP	RX	No	No

International Patents for Eugia Pharma Drugs

Country	Patent Number	Estimated Expiration
European Patent Office	3139929
Canada	2948148
World Intellectual Property Organization (WIPO)	2015171460
Russian Federation	2016147362
Japan	6516831
Australia	2015256331
Brazil	112016026140

Supplementary Protection Certificates for Eugia Pharma Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1189916	2011C/004	Belgium		PRODUCT NAME: REGADENOSON; AUTHORISATION NUMBER AND DATE: EU/1/10/643/001 20100906
0275821	01C0035	France		PRODUCT NAME: ZOLEDRONIC ACID; NAT REG. NO/DATE: EU/1/01/176/001 20010320; FIRST REG.: LI IKS N 55 463 20001128
2785706	C02785706/01	Switzerland		PRODUCT NAME: FOSNETUPITANT, PALONOSETRON.; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68290 01.09.2022
2563920	CR 2019 00001	Denmark		PRODUCT NAME: INOTERSEN AND SALT THEREOF, INCLUDING SODIUM SALTS; REG. NO/DATE: EU/1/18/1296 20180710
1856135	2090014-8	Sweden		PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE OR SOLVATE OF FOSTAMATINIB OR THE PH ARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113
0863901	PA2004008	Lithuania		PRODUCT NAME: ERTAPENEMUM ([4R,5S,6S]-3-[(3S,5S)-5-[(3-KARBOKSIFENIL) AMINO]KARBONIL]-3-PIROLIDINIL]TIO]-6-[(1R)-1HIDROKSIETIL]-4-METIL-7-OKSO-1-AZABICIKLO-[3.2.0]HEPT-2-EN-2-KARBOKSIRUGSTIS; REGISTRATION NO/DATE: 03/8043/3 20030328
0296749	09C0055	France		PRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME D’UN SEL D’ADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; REGISTRATION NO/DATE IN FRANCE: NL 21126 DU 19961227; REGISTRATION NO/DATE AT EEC: 12619/0106 DU 19950811

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Eugia Pharma
• Eugia Pharma Speclts